Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.2.17EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BG.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.4.1.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.576EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.325EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.22EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.521EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.378EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.206EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.28EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.77EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.13.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HV.1.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.2.3.16EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BM.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBEEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BE.1.4.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.3.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.3.14EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.93 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.31.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GW.5.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.38EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.2.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DN.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.3.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.4.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BW.1.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.2.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.312EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.13.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.220EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.142EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.523EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
C.36.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.418EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.389EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.53EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.363EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HV.1.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.405EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.282EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.228EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.174EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.88 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.106 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.346EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.93EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used